Potential role of presenilin-regulated signaling pathways in sporadic neurodegeneration

Nature Medicine

Volumn 10, Issue 7, 2004, Pages S26-

  Koo, Edward H ^a   Kopan, Raphael ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRESENILIN 1;

AGE; ALZHEIMER DISEASE; ARTICLE; DEGENERATIVE DISEASE; GENE MUTATION; GENETIC ANALYSIS; HEREDITY; HUMAN; NERVE DEGENERATION; NEUROPATHOLOGY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DEGRADATION; REGULATORY MECHANISM; REVIEW;

ANIMALS; APOPTOSIS; CASPASES; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MEMBRANE PROTEINS; MODELS, NEUROLOGICAL; NERVE DEGENERATION; NEURODEGENERATIVE DISEASES; PRESENILIN-1; PRESENILIN-2; PROTO-ONCOGENE PROTEINS; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 3142512452     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm1065     Document Type: Article

References (111)

1. Katzman, R. Alzheimer’s disease. N. Engl. J. Med. 314, 964-973 (1986).
2. Terry, R.D. et al. Physical basis of cognitive alterations in Alzheimer’s disease: Synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30, 572-580 (1991).
3. Selkoe, D.J. Alzheimer’s disease is a synaptic failure. Science 298, 789-791 (2002).
4. Hardy, J. & Selkoe, D.J. The amyloid hypothesis of Alzheimer’s disease: Progress and problems on the road to therapeutics. Science 297, 353-356 (2002).
5. Terry, R.D. An honorable compromise regarding amyloid in Alzheimer disease. Ann. Neurol. 49, 684 (2001).
6. Kirkitadze, M.D., Bitan, G. & Teplow, D.B. Paradigm shifts in Alzheimer’s disease and other neurodegenerative disorders: The emerging role of oligomeric assemblies. J. Neurosci. Res. 69, 567-577 (2002).
7. Vassar, R. et al. p-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286, 735-741 (1999).
8. Brown, M.S., Ye, J., Rawson, R.B. & Goldstein, J.L. Regulated intramembrane proteolysis: A control mechanism conserved from bacteria to humans. Cell 100, 391-398 (2000).
9. Rogaev, E.I. et al. Familial Alzheimer’s disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer’s disease type 3 gene. Nature 376, 775-778 (1995).
10. Weihofen, A., Binns, K., Lemberg, M.K., Ashman, K., & Martoglio, B. Identification of signal peptide peptidase, a presenilin-type aspartic protease. Science296, 2215-2218 (2002).
11. Wolfe, M.S. et al. Two transmembrane aspartates in presenilin-1 required for pre- senilin endoproteolysis and y-secretase activity. Nature 398, 513-517 (1999).
12. Xia, W. & Wolfe, M.S. Intramembrane proteolysis by presenilin and presenilin-like proteases. J. Cell Sci. 116, 2839-2844 (2003).
13. Edbauer, D. et al. Reconstitution of y-secretase activity. Nat. Cell Biol. 5, 486-488 (2003).
14. Kimberly, W.T. et al. y-Secretase is a membrane protein complex comprised of presenilin, nicastrin, Aph-1, and Pen-2. Proc. Natl. Acad. Sci. USA 100, 6382-6387 (2003).
15. Takasugi, N. et al. The role of presenilin cofactors in the y-secretase complex. Nature 422, 438-441 (2003).
16. Luo, W.J. et al. PEN-2 and APH-1 coordinately regulate proteolytic processing of presenilin 1. J. Biol. Chem. 278, 7850-7854 (2003).
17. Selkoe, D. & Kopan, R. Notch and Presenilin: Regulated intramembrane proteoly- sis links development and degeneration. Annu. Rev. Neurosci. 26, 565-597 (2003).
18. Jarrett, J.T., Berger, E.P. & Lansbury, P.T.J. The carboxy terminus of the p amyloid protein is critical for the seeding of amyloid formation: Implications for the patho- genesis of Alzheimer’s disease. Biochemistry 32, 4693-4697 (1993).
19. Yankner, B.A. Mechanisms of neuronal degeneration in Alzheimer’s disease. Neuron16, 921-932 (1996).
20. Murayama, O. et al. Enhancement of amyloid p42 secretion by 28 different presenilin 1 mutations of familial Alzheimer’s disease. Neurosci. Lett. 265, 61-63 (1999).
21. Teller, J.K. et al. Presence of soluble amyloid p-peptide precedes amyloid plaque formation in Down’s syndrome. Nat. Med. 2, 93-95 (1996).
22. Prasher, V.P. et al. Molecular mapping of Alzheimer-type dementia in Down’s syndrome. Ann. Neurol. 43, 380-383 (1998).
23. Corder, E.H. et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 261, 921-923 (1993).
24. Bales, K.R. et al. Lack of apolipoprotein E dramatically reduces amyloid p-peptide deposition. Nat. Genet. 17, 263-264 (1997).
25. DeMattos, R.B. et al. ApoE and clusterin cooperatively Ssuppress Ap levels and deposition. Evidence that ApoE regulates extracellular Ap metabolism in vivo. Neuron 41, 193-202 (2004).
26. Wolozin, B. et al. Participation of presenilin 2 in apoptosis: Enhanced basal activity conferred by an Alzheimer mutation. Science 274, 1710-1713 (1996).
27. Guo, Q. et al. Alzheimer’s presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid p-peptide. J. Neurosci. 272, 3590-3598 (1997).
28. Chui, D. et al. Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation. Nature 5, 560-564 (1999).
29. Guo, Q. et al. Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice. Nat. Med. 5, 101-106 (1999).
30. Siman, R. et al. Presenilin-1 P264L knock-in mutation: Differential effects on Ap production, amyloid deposition, and neuronal vulnerability. J. Neurosci. 20, 8717-8726 (2000).
31. Saura, C.A. et al. Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration. Neuron 42, 23-36 (2004).
32. Rozmahel, R. et al. Normal brain development in PS1 hypomorphic mice with markedly reduced y-secretase cleavage of pAPP. Neurobiol. Aging 23, 187-194 (2002).
33. Leissring, M.A. et al. Capacitative calcium entry deficits and elevated luminal calcium content in mutant presenilin-1 knockin mice. J. Cell Biol. 149, 793-798 (2000).
34. Yoo, A.S. et al. Presenilin-mediated modulation of capacitative calcium entry. Neuron27, 561-572 (2000).
35. Mattson, M.P., Chan, S.L. & Camandola, S. Presenilin mutations and calcium signaling defects in the nervous and immune systems. Bioessays 23, 733-744 (2001).
36. LaFerla, F.M. Calcium dyshomeostasis and intracellular signalling in Alzheimer’s disease. Nat. Rev. Neurosci. 3, 862-872 (2002).
37. Yang, Y. & Cook, D.G. Presenilin-1 deficiency impairs glutamate-evoked intracel- lular calcium responses in neurons. Neuroscience 124, 501-505 (2004).
38. De Strooper, B. et al. A presenilin-1-dependent y-secretase-like protease mediates release of Notch intracellular domain. Nature 398, 518-522 (1999).
39. Mumm, J.S. et al. A ligand-induced extracellular cleavage regulates y-secretase- like proteolytic activation of Notch1. Mol. Cell 5, 197-206 (2000).
40. Artavanis-Tsakonas, S., Rand, M.D. & Lake, R.J. Notch signaling: Cell fate control and signal integration in development. Science 284, 770-776 (1999).
41. Gaiano, N. & Fishell, G. The role of notch in promoting glial and neural stem cell fates. Annu. Rev. Neurosci. 25, 471-490 (2002).
42. Presente, A., Andres, A. & Nye, J.S. Requirement of Notch in adulthood for neurological function and longevity. NeuroReport 12, 3321-3325 (2001).
43. Presente, A., Boyles, R.S., Serway, C.N., De Belle, J.S. & Andres, A.J. Notch is required for long-term memory in Drosophila. Proc. Natl. Acad. Sci USA 101, 1764-1768 (2004).
44. Costa, R.M., Honjo, T. & Silva, A.J. Learning and memory deficits in Notch mutant mice. Curr. Biol. 13, 1348-1354 (2003).
45. Feng, R. et al. Deficient neurogenesis in forebrain-specific presenilin-1 knockout mice is associated with reduced clearance of hippocampal memory traces. Neuron 323, 911-926 (2001).
46. Hitoshi, S. et al. Notch pathway molecules are essential for the maintenance, but not the generation, of mammalian neural stem cells. Genes Dev. 16, 846-858 (2002).
47. Redmond, L. & Ghosh, A. The role of Notch and Rho GTPase signaling in the control of dendritic development. Curr. Opin. Neurobiol. 11, 111-117 (2001).
48. Berezovska, O. et al. Notch1 inhibits neurite outgrowth in postmitotic primary neurons. Neuroscience 93, 433-439 (1999).
49. Sestan, N., Artavanis-Tsakonas, S. & Rakic, P. Contact-dependent inhibition of cortical neurite growth mediated by notch signaling. Science 286, 741-746 (1999).
50. Berezovska, O., Xia, M.Q. & Hyman, B.T. Notch is expressed in adult brain, is coexpressed with presenilin-1, and is altered in Alzheimer disease. J. Neuropathol. Exp. Neurol. 57, 738-745 (1998).
51. Herreman, A. et al. Total inactivation of y-secretase activity in presenilin-deficient embryonic stem cells. Nat. Cell Biol. 2, 461-462 (2000).
52. Donoviel, D.B. et al. Mice lacking both presenilin genes exhibit early embryonic patterning defects. Genes Dev. 13, 2801-2810 (1999).
53. Schroeter, E.H. et al. A presenilin dimer at the core of the y-secretase enzyme: Insights from parallel analysis of Notch 1 and APP proteolysis. Proc. Natl. Acad. Sci. USA100, 13075-13080 (2003).
54. Moehlmann, T. et al. Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Ap 42 production. Proc. Natl. Acad. Sci. USA 99, 8025-8030 (2002).
55. Song, W., Nadeau, P., Yuan, X., Shen, J. & Yankner, B.A. Proteolytic release and nuclear translocation of Notch-1 are induced by presenilin-1 and impaired by pathogenic presenilin-1 mutations. Proc. Natl. Acad. Sci. USA 96, 6959-6963 (1999).
56. Kwok, J.B. et al. Presenilin-1 mutation L271V results in altered exon 8 splicing and Alzheimer’s disease with non-cored plaques and no neuritic dystrophy. J. Biol. Chem. 278, 6748-6754 (2003).
57. Amtul, Z. et al. A presenilin 1 mutation associated with familial frontotemporal dementia inhibits y-secretase cleavage of APP and notch. Neurobiol. Dis. 9, 269-273 (2002).
58. Lleo, A. et al. Notchl competes with the amyloid precursor protein for y-secretase and down-regulates presenilin-1 gene expression. J. Biol. Chem. 278, 47370-47375 (2003).
59. Scheuner, D. et al. Secreted amyloid p-protein similar to that in the senile plaques of Alzheimer’s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer’s disease. Nat. Med. 2, 864-870 (1996).
60. Cupers, P., Orlans, I., Craessaerts, K., Annaert, W. & De Strooper, B. The amyloid precursor protein (APP)-cytoplasmic fragment generated by y-secretase is rapidly degraded but distributes partially in a nuclear fraction of neurones in culture. J. Neurochem. 78, 1168-1178 (2001).
61. Sastre, M. et al. Presenilin-dependent y-secretase processing of p-amyloid precursor protein at a site corresponding to the S3 cleavage of Notch. EMBO Rep. 2, 835-841 (2001).
62. Kimberly, W.T., Zheng, J.B., Guenette, S.Y. & Selkoe, D.J. The intracellular domain of the p-amyloid precursor protein is stabilized by Fe65 and translocates to the nucleus in a notch-like manner. J. Biol. Chem. 276, 40288-40292 (2001).
63. Cao, X. & Sudhof, T.C. A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 293, 115-120 (2001).
64. Scheinfeld, M.H., Ghersi, E., Laky, K., Fowlkes, B.J. & D’Adamio, L. Processing of p-amyloid precursor-like protein-1 and -2 by y-secretase regulates transcription. J. Biol. Chem. 277, 44195-44201 (2002).
65. Gao, Y. & Pimplikar, S.W. The y-secretase-cleaved C-terminal fragment of amyloid precursor protein mediates signaling to the nucleus. Proc. Natl. Acad. Sci USA 98, 14979-14984 (2001).
66. Baek, S.-H. et al. Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-KB and p-amyloid precursor protein. Cell 110, 55-67 (2002).
67. Zhao, Q. & Lee, F.S. The transcriptional activity of the APP intracellular domain- Fe65 complex is inhibited by activation of the NF-KB pathway. Biochemistry 42, 3627-3634 (2003).
68. Mattson, M.P. Cellular actions of p-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol. Rev. 77, 1081-1132 (1997).
69. Turner, P.R., O’Connor, K., Tate, W.P. & Abraham, W.C. Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory. Prog. Neurobiol. 70, 1-32 (2003).
70. Zheng, H. et al. p-amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity. Cell81, 525-531 (1995).
71. Heber, S. et al. Mice with combined gene knock-outs reveal essential and partially redundant functions of amyloid precursor protein family members. J. Neurosci. 20, 7951-7963 (2001).
72. von Koch, C.S. et al. Generation of APLP2 KO mice and early postnatal lethality in APLP2/APP double KO mice. Neurobiol. Aging 18, 661-669 (1997).
73. Leissring, M.A. et al. A physiologic signaling role for the y-secretase-derived intracellular fragment of APP. Proc. Natl. Acad. Sci. USA 99, 4697-4702 (2002).
74. Yankner, B.A. et al. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer’s disease. Science 245, 417-420 (1989).
75. Neve, R.L., McPhie, D.L. & Chen, Y. Alzheimer’s disease: A dysfunction of the amyloid precursor protein. Brain Res. 886, 54-66 (2000).
76. Suh, Y.H. An etiological role of amyloidogenic carboxyl-terminal fragments of the p-amyloid precursor protein in Alzheimer’s disease. J. Neurochem. 68, 1781-1791 (1997).
77. Passer, B. et al. Generation of an apoptotic intracellular peptide by y-secretase cleavage of Alzheimer’s amyloid p protein precursor. J. Alzheimer’s Dis. 2, 289-301 (2000).
78. Hashimoto, Y. et al. The cytoplasmic domain of Alzheimer’s amyloid-p protein precursor causes sustained apoptosis signal-regulating kinase 1/c-Jun NH2-terminal kinase-mediated neurotoxic signal via dimerization. J. Pharmacol. Exp. Ther. 306, 889-902 (2003).
79. Lu, D.C. et al. A second cytotoxic proteolytic peptide derived from amyloid p-pro- tein precursor. Nat. Med. 6, 397-404 (2000).
80. Lu, D.C., Shaked, G.M., Masliah, E., Bredesen, D.E. & Koo, E.H. Amyloid p protein toxicity mediated by the formation of amyloid-p protein precursor complexes. Ann. Neurol. 54, 781-789 (2003).
81. Ikeuchi, T. & Sisodia, S.S. The Notch ligands, Delta1 and Jagged2, are substrates for presenilin-dependent “y-secretase” cleavage. J. Biol. Chem. 278, 7751-7754 (2003).
82. Taniguchi, Y., Kim, S.H. & Sisodia, S.S. Presenilin-dependent “y-secretase” processing of deleted in colorectal cancer (DCC). J. Biol. Chem. 278, 30425-30428 (2003).
83. LaVoie, M.J. & Selkoe, D.J. The Notch ligands, Jagged and Delta, are sequentially processed by y-secretase and presenilin/y-secretase and release signaling fragments. J. Biol. Chem. 278, 34427-34437 (2003).
84. Ni, C.Y., Murphy, M.P., Golde, T.E. & Carpenter, G. y-secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. Science 294, 2179-2181 (2001).
85. Jung, K.M. et al. Regulated intramembrane proteolysis of the p75 neurotrophin receptor modulates its association with the TrkA receptor. J. Biol. Chem. 278, 42161-42169 (2003).
86. Kim, D.Y., Ingano, L.A. & Kovacs, D.M. Nectin-1a, an immunoglobulin-like receptor involved in the formation of synapses, is a substrate for presenilin/y-secretase- like cleavage. J. Biol. Chem. 277, 49976-49981 (2002).
87. Lee, H.J. et al. Presenilin-dependent y-secretase-like intramembrane cleavage of ErbB4. J. Biol. Chem. 277, 6318-6323 (2002).
88. May, P., Reddy, Y.K. & Herz, J. Proteolytic processing of low density lipoprotein receptor-related protein mediates regulated release of its intracellular domain. J. Biol. Chem. 277, 18736-18743 (2002).
89. Marambaud, P. et al. A CBP binding transcriptional repressor produced by the PS1/s-cleavage of N-cadherin is inhibited by PS1 FAD mutations. Cell 114, 635-645 (2003).
90. Marambaud, P. et al. A presenilin-1/y-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions. EMBO J. 21, 1948-1956 (2002).
91. Lammich, S. et al. Presenilin-dependent intramembrane proteolysis of CD44 leads to the liberation of its intracellular domain and the secretion of an Ap-like peptide. J. Biol. Chem. 277, 44754-44759 (2002).
92. Schulz, J.G. et al. Syndecan 3 intramembrane proteolysis is presenilin/y-secre- tase-dependent and modulates cytosolic signaling. J. Biol. Chem. 278, 48651-48657 (2003).
93. May, P., Bock, H.H., Nimpf, J. & Herz, J. Differential glycosylation regulates processing of lipoprotein receptors by y-secretase. J. Biol. Chem. 278, 37386-37392 (2003).
94. Murakami, D. et al. Presenilin-dependent y-secretase activity mediates the intramembranous cleavage of CD44. Oncogene22, 1511-1516 (2003).
95. Struhl, G. & Adachi, A. Requirements for presenilin-dependent cleavage of notch and other transmembrane proteins. Mol. Cell 6, 625-636 (2000).
96. Kopan, R. & Ilagan, X.G. y-secretase: Proteosome of the membrane? Nat. Rev. Mol. Cell Biol., in press.
97. Crone, S.A. & Lee, K.F. Gene targeting reveals multiple essential functions of the neuregulin signaling system during development of the neuroendocrine and nervous systems. Ann. NY Acad. Sci. 971, 547-553 (2002).
98. Livesey, F.J. Netrins and netrin receptors. Cell Mol. Life Sci. 56, 62-68 (1999).
99. Chao, M.V. Neurotrophins and their receptors: A convergence point for many signalling pathways. Nat. Rev. Neurosci. 4, 299-309 (2003).
100. Yaar, M. et al. Binding of p-amyloid to the p75 neurotrophin receptor induces apoptosis. A possible mechanism for Alzheimer’s disease. J. Clin. Invest 100, 2333-2340 (1997).
101. Wang, K.C., Kim, J.A., Sivasankaran, R. & He, Z. p75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG, and OMgp. Nature 420, 74-78 (2002).
102. Okamoto, I. et al. Proteolytic release of CD44 intracellular domain and its role in the CD44 signaling pathway. J. Cell Biol. 155, 755-762 (2001).
103. Jiang, H., Nucifora, F.C., Jr., Ross, C.A. & DeFranco, D.B. Cell death triggered by polyglutamine-expanded huntingtin in a neuronal cell line is associated with degradation of CREB-binding protein. Hum. Mol. Genet. 12, 1-12 (2003).
104. Phiel, C.J., Wilson, C.A., Lee, V.M. & Klein, P.S. GSK-3_ regulates production of Alzheimer’s disease amyloid-p peptides. Nature 423, 435-439 (2003).
105. Takashima, A. et al. Presenilin 1 associates with glycogen synthase kinase-3p and its substrate tau. Proc. Natl. Acad. Sci. USA 95, 9637-9641 (1998).
106. Lucas, J.J. et al. Decreased nuclear p-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3p conditional transgenic mice. EMBO J. 20, 27-39 (2001).
107. Barker, N., Morin, P.J. & Clevers, H. The yin-yang of TCF/p-catenin signaling. Adv. Cancer Res. 77, 1-24 (2000).
108. Liu, C. et al. Control of p-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 108, 837-847 (2002).
109. Kang, D.E. et al. Presenilin couples the paired phosphorylation of p-catenin independent of axin: Implications for p-catenin activation in tumorigenesis. Cell110, 751-762 (2002).
110. Soriano, S. et al. Presenilin 1 negatively regulates p-catenin/T cell factor/lymphoid enhancer factor-1 signaling independently of p-amyloid precursor protein and Notch processing. J. Cell Biol. 152, 785-794 (2001).
111. Annaert, W.G. et al. Interaction with telencephalin and the amyloid precursor protein predicts a ring structure for presenilins. Neuron 32, 579-589 (2001).